Oxcia - Crunchbase Company Profile & Funding

Q: Where is Oxcia's headquarters?

Oxcia is located in Stockholm, Stockholms Lan, Sweden.

Q: Who invested in Oxcia?

Oxcia has 3 investors including European Innovation Council And Swelife.

Q: When was the last funding round for Oxcia?

Oxcia closed its last funding round on obfuscated from a Grant round.

Overview

Oxcia

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+4 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Oxcia

CB Rank

26779

Oxcia is a biopharmaceutical company that provides therapies and DNA damage response mechanisms to treat cancer and inflammatory diseases.

Founded

obfuscation

Private

Grant

Stockholm, Stockholms Lan, Sweden

11-50

oxcia.com

Health Care

Pharmaceutical

Therapeutics

Funding Rounds

Grant

OBF

obfuscation

Grant

OBF

obfuscation

Details

Legal Name

Oxcia AB

Operating Status

Active

Company Type

For Profit

Phone Number

+46 073 270 96 05

Contact Email

info@oxcia.com

Predictions & Insights

Growth Insight

See this Growth Insight

Oxcia is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

OXC-101

An oral mitotic MTH1 inhibitor designed to target cancer cells by exploiting their high oxidative stress and DNA damage.

OXC-201

An oral small molecule inhibitor of the DNA repair enzyme OGG1, developed to treat idiopathic pulmonary fibrosis and other inflammatory and fibrotic diseases.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Oxcia	1	obfuscated obfuscation	European Innovation Council	Grant
obfuscated obfuscation	Grant - Oxcia	1	obfuscated obfuscation	European Innovation Council	Grant
obfuscated obfuscation	Grant - Oxcia	1	obfuscated obfuscation	European Innovation Council	Grant
obfuscated obfuscation	Grant - Oxcia	1	obfuscated obfuscation	European Innovation Council	Grant
obfuscated obfuscation	Grant - Oxcia	1	obfuscated obfuscation	European Innovation Council	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Oxcia	1	obfuscated obfuscation	European Innovation Council	Grant
obfuscated obfuscation	Grant - Oxcia	1	obfuscated obfuscation	European Innovation Council	Grant
obfuscated obfuscation	Grant - Oxcia	1	obfuscated obfuscation	European Innovation Council	Grant
obfuscated obfuscation	Grant - Oxcia	1	obfuscated obfuscation	European Innovation Council	Grant
obfuscated obfuscation	Grant - Oxcia	1	obfuscated obfuscation	European Innovation Council	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
European Innovation Council	Yes	Grant - Oxcia	—
European Innovation Council	Yes	Grant - Oxcia	—
European Innovation Council	Yes	Grant - Oxcia	—
European Innovation Council	Yes	Grant - Oxcia	—
European Innovation Council	Yes	Grant - Oxcia	—